Budget Impact Analysis of Formoterol Easyhaler in the Treatment of Asthma in Children in the Russian Federation

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.09.1396
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prs48 - Cost – Effectiveness Analysis of Vilanterol/Fluticasone Furoate for Asthma Treatment in the Russian Federation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Budget Impact Analysis or Pharmacological Therapy of Chronic Myeloid Leukemia (Cml) With Nilotinib as the Second-Line Treatment in Russian Federation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Pcn90 - Cost-Effectiveness and Budget Impact Analysis of Nilotinib for the Second Line Tratment of Chronic Mieloid Leukemia in the Russian Federation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Analysis of Emergency Situations in the Russian Federation

Prehospital and Disaster Medicine
Emergency NursingEmergency Medicine
2019English

Impact Analysis of Internal and External Risks on the Federal Budget of the Russian Federation and the Ways of Risk Minimization

Interactive science
2017English

The Role of Animated Characters in the Socialization of Children in the Russian Federation

International Journal of Engineering and Technology(UAE)
ArchitectureHardwareEngineeringChemical EngineeringBiotechnologyEnvironmental EngineeringComputer Science
2018English

Budget Impact Evaluation of Treatment With a Low Protein Diet and Ketoanalogues of Essential Aminoacids for Predialysis Patients in Russian Federation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Reserve Funds of the President of the Russian Federation and Government of the Russian Federation in the Federal Budget: Dynamic Performance and Changes in Their Formation and Use in 2017

Financial Analytics: Science and Experience
2018English

Pcn81 - Budget Impact Analysis of Cdk4/6 Inhibitors for the First Line Theraphy of Hr-Positive Her2-Negative Advanced Breast Cancer in the Russian Federation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy